2021 annual financial data

Aurinia Pharmaceuticals 2021 Financial results

Direct answer

Revenue was 45,605,000 USD.

Operating income was -180,735,000 USD and net income was -180,966,000 USD.
Operating cash flow was -157,692,000 USD.

Get free Aurinia Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
45,605,000 USD
Operating income
-180,735,000 USD
Net income
-180,966,000 USD
Operating cash flow
-157,692,000 USD